Englewood Cardiology Consultant Englewood, NJ - 07631

Englewood Cardiology Consultant is categorized under Doctors in Englewood, NJ and active since 1997.

Englewood Cardiology Consultant was established in 1997, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Jay Erlebacher at the company’s single location by writing to 177 North Dean St, Englewood, New Jersey NJ 07631 or by phoning (201) 569-4901. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Englewood Cardiology Consultant
Contact Person: Jay Erlebacher
Address: 177 North Dean St, Englewood, New Jersey 07631
Phone Number: (201) 569-4901
Website Address: cardiologyconsultants.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Englewood Cardiology Consultant was started in 1997 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Jay Erlebacher for inquiries that concern Englewood Cardiology Consultant by calling the company number (201) 569-4901, as your correspondence is most welcome. Additionally, the physical location of the single location of Englewood Cardiology Consultant can be found at the coordinates 40.899833,-73.970833 as well as the street address 177 North Dean St in Englewood, New Jersey 07631.

For its online presence, you may visit Englewood Cardiology Consultant’s website at cardiologyconsultants.com and engage with its social media outlets through on Twitter and on Facebook.